Innovative Technologies Impacted by COVID–19 Act
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 14, 2022
Introduced in House
Dec 14, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Innovative Technologies Impacted by COVID-19 Act
This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.
What's happening now
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cosponsors
4
Cite this page
U.S. Congress. (2026). H.R. 9559: Innovative Technologies Impacted by COVID–19 Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-9559/
"H.R. 9559: Innovative Technologies Impacted by COVID–19 Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-9559/.
H.R. 9559, 117th Cong. (2026), https://openamerica.io/bill/117-HR-9559/.
[H.R. 9559: Innovative Technologies Impacted by COVID–19 Act](https://openamerica.io/bill/117-HR-9559/)